NET/EE

DRUG2 trials

Sponsors

Vertex Pharmaceuticals Incorporated

Conditions

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Phase 1

Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy Participants

CompletedNCT07074327

Vertex Pharmaceuticals IncorporatedAutosomal Dominant Polycystic Kidney Disease (ADPKD)

Start: 2025-07-11End: 2026-02-27Updated: 2026-03-30

Effects of VX-407 on the Pharmacokinetics of Combined Oral Contraceptives

Not yet recruitingNCT07792408

Vertex Pharmaceuticals IncorporatedAutosomal Dominant Polycystic Kidney Disease (ADPKD)

Start: 2026-08-28End: 2027-03-20Target: 148Updated: 2026-08-28